Johnson & Johnson Innovation
Investment Details
Investor Type
Corporate VC
Asset Class Focus
Venture Capital
Stage Focus
Seed, Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO
Geographical Focus
United States, United Kingdom, Canada, Germany, Japan, Australia, Singapore, China, India, France, Italy, United Arab Emirates, Switzerland, Spain, South Korea, Netherlands, Sweden, Belgium, Israel, Taiwan
Industries Focus
- Healthcare
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Biotechnology
- Regenerative Medicine
- Oncology
- Infectious Diseases
- Consumer Health
- Vaccines
- Immunology
- Rare Diseases
- Medical Technology
- Cardiovascular
- Neuroscience
- Cell and Gene Therapy
- Surgical Robotics
- Pulmonary Hypertension
- Metabolic Diseases
Investment Size:
1,000,000 to 50,000,000 USD
Investor Details Founded: 2013
Johnson & Johnson Innovation is a global network that partners with external innovators to bring new healthcare solutions to market. The organization operates through various platforms, including JLABS, which provides early-stage companies with access to Johnson & Johnson's resources, and JJDC, Inc., which offers venture capital funding. These platforms support innovations across pharmaceuticals, medical devices, and consumer health sectors.
The organization's strategy focuses on fostering collaborations with entrepreneurs, startups, and academic institutions to accelerate the development of transformative healthcare solutions. By leveraging Johnson & Johnson's extensive expertise and infrastructure, Johnson & Johnson Innovation aims to address unmet medical needs and improve patient outcomes worldwide.
With a global presence, Johnson & Johnson Innovation has established innovation centers and incubators in key life science hubs, including Boston, London, San Francisco, and Shanghai. These centers serve as gateways for innovators to access a wide range of resources, including early-stage research funding, licensing opportunities, and integrated healthcare solutions, facilitating the advancement of promising healthcare innovations.
Requirements
- Innovative healthcare solutions
- Early-stage companies
- Collaborations with entrepreneurs and startups
- Licensing opportunities
- Integrated healthcare solutions
- Access to early-stage research funding
- Global healthcare impact
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Actelion Pharmaceuticals Ltd.
- Janssen Pharmaceuticals
- Kenvue Inc.
- Janssen Biotech, Inc.
- Janssen Research & Development, LLC
- Janssen Immunology
- Janssen Oncology
- Janssen Neuroscience
- Janssen Cardiovascular & Metabolism
- Janssen Infectious Diseases & Vaccines
- Janssen Pulmonary Hypertension
- Janssen Medical Devices
- Janssen Diagnostics
- Janssen Digital Health
- Janssen Cell and Gene Therapy
- Janssen Regenerative Medicine
- Janssen Vaccines
- Janssen Cell Therapy
- Janssen Gene Therapy
Claim this Investor
Are you an official representative of Johnson & Johnson Innovation?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim